Announcements Trials
Browse Landscape

Status

Unknown 2Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Esophageal Neoplasms 9Melanoma 6Lung Neoplasms 6Squamous Cell Carcinoma of Head and Neck 4Small Cell Lung Carcinoma 4Esophageal Squamous Cell Carcinoma 4Colorectal Neoplasms 4Carcinoma, Hepatocellular 4Stomach Neoplasms 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Uterine Cervical Neoplasms 2Neoplasms 2Nasopharyngeal Carcinoma 2Carcinoma, Transitional Cell 2Unresectable Biliary Tract Cancer 1Thymus Neoplasms 1Thymoma 1Thymic epithelial tumor 1Small Cell Lung Cancer Extensive Stage 1Recurrence 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pinealoma 1Pathologic Complete Response 1Neuroblastoma 1Neoplasms, Germ Cell and Embryonal 1Nasopharyngeal Neoplasms 1Muscle-Invasive Bladder Carcinoma 1

Interventions

Cyclophosphamide 23venetoclax 17Dexamethasone 16pembrolizumab 15fludarabine 15Cytarabine 13pomalidomide 8Rituximab 8Gemcitabine 8Carboplatin 8Azacitidine 8glofitamab 7fludarabine phosphate 7Lenalidomide 7selinexor 6Paclitaxel 6Injections 6Immunotherapy, Adoptive 6Granulocyte Colony-Stimulating Factor 6Cisplatin 6daratumumab 5Temozolomide 5Bevacizumab 5zanubrutinib 4ruxolitinib 4Surgical Procedures, Operative 4Oxaliplatin 4Nivolumab 4Drug Therapy 4Decitabine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Recurrence × Immunotherapy × Clear all
NCT06197776 2026-05-11

Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC

Sun Yat-sen University

Recruiting
50 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡